Recently, BGI Genomics' COLOTECT™ 1.0 DNA Methylation Detection Kit for Human SDC2, ADHFE1, and PPP2R5C Genes (Real-Time PCR), Sample Pretreatment Kit for Methylation Detection, DNA Isolation Kit, ...
Recently, BGI Genomics' COLOTECT ™ 1.0 DNA Methylation Detection Kit for Human SDC2, ADHFE1, and PPP2R5C Genes (Real-Time PCR), Sample Pretreatment Kit for Methylation Detection, DNA Isolation Kit, ...
COPENHAGEN, Denmark--(BUSINESS WIRE)--COLOTECT™ 3.0 is a non-invasive colorectal cancer screening test developed by BGI, and will be launched in early 2023. BGI plans to release pre-clinical ...
HONG KONG SAR – Media OutReach – 28 November 2022 – COLOTECT™ Test Kit has obtained the Certificate of IVD from HKSAR Department of Health.COLOTECT™ is a non-invasive colorectal cancer (CRC) ...
SAN FRANCISCO, Feb. 7, 2023 /PRNewswire/ -- COLOTECT 3.0, a multi-target fecal DNA test outperforms fecal immunochemical tests (FIT) in terms of detection of colorectal cancer and advanced ...
COLOTECT is a non-invasive colorectal cancer (CRC) self-sampling test that can detect the methylation status of exfoliated cell genes in the intestine, help screen for colorectal cancer and ...
COLOTECT 3.0 is a non-invasive colorectal cancer screening test developed by BGI, and will be launched in early 2023. BGI plans to release pre-clinical case-control data for COLOTECT 3.0 at the 2023 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results